The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study

EuroIntervention 2011;7:689-696. DOI: 10.4244/EIJV7I6A111

1. Institut Hospitalier Jacques Cartier, Massy, France; 2. Clinique Saint-Augustin, Bordeaux, France; 3. INSERM, U970, Paris Cardiovascular Research Centre PARCC, Paris, France & Université Paris Descartes, UMR-S970, Paris, Fr

Aims: We sought to assess the efficacy and safety of everolimus-eluting stents for unprotected left main disease.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study